Goldman Sachs Gains 2 Board Seats With Burst Subscription Oral Care Investment
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.
You may also be interested in...
The firm says during COVID-19 pandemic, it is waiving the $20 registration fee for its Burst Ambassador program to assist dental hygienists whose offices have closed temporarily, or remain open but put them at risk through close contact with patients and co-workers, potential contamination of saliva and shortage of protective equipment.
FDA’s latest COVID-19 warnings note fewer violative claims than identified in previous warnings to consumer health firms. One had a single noncompliant claim on its website, while another’s violations included identifying potential symptoms of COVID-19. Four men associated with a Florida church face counts of conspiracy to defraud the US and of contempt of court stemming from COVID-1 claims for a bleach solution.
Pataday Once Daily Relief Extra Strength is the same formulation as Novartis' Rx Pazeo. It will be the first OTC eye drop indicated for allergy itch with 24-hour efficacy, available online in September and through retailers in early 2021.